Akebia Therapeutics (AKBA) Change in Cash (2013 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Change in Cash of -$22.2 million for Q1 2026, down 136.08% year-over-year from $61.5 million in Q1 2025, and down 220.6% quarter-over-quarter from $18.4 million in Q4 2025.
Akebia Therapeutics (AKBA) Change in Cash (2013 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Change in Cash for 14 consecutive years, with -$22.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 136.08% year-over-year to -$22.2 million; the TTM figure through Mar 2026 stood at $49.3 million (down 31.0% YoY), while the FY2025 annual figure was $133.0 million, up 1382.48% from the prior year.
- Change in Cash eased to -$22.2 million in Q1 2026 per AKBA's latest filing, from $18.4 million in the prior quarter.
- Across five years, Change in Cash topped out at $61.5 million in Q1 2025 and bottomed at -$54.7 million in Q4 2022.
- Historically, Change in Cash has averaged $735823.5 across 5 years, with a median of -$2.5 million in 2024.
- Annual changes were most pronounced in 2023 — Change in Cash tumbled 919.93% — and 2025, when it jumped 6527.27%.
- Akebia Therapeutics' Change in Cash stood at -$54.7 million in 2022, then surged by 93.42% to -$3.6 million in 2023, then jumped by 596.3% to $17.9 million in 2024, then increased by 3.06% to $18.4 million in 2025, then slumped by 220.6% to -$22.2 million in 2026.
- Business Quant data shows AKBA's Change in Cash at -$22.2 million in Q1 2026, $18.4 million in Q4 2025, and $29.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Akebia Therapeutics | 244.72 Mn | 89.17 Mn | 38.70 Mn | -7.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.09 Mn |
| Mar 31, 2026 | -22.20 Mn |
| Dec 31, 2025 | 18.40 Mn |
| Sep 30, 2025 | 29.14 Mn |
| Jun 30, 2025 | 23.94 Mn |
| Mar 31, 2025 | 61.51 Mn |
| Dec 31, 2024 | 17.86 Mn |
| Sep 30, 2024 | -5.47 Mn |
| Jun 30, 2024 | -2.46 Mn |
| Mar 31, 2024 | -957,000.00 |
| Dec 31, 2023 | -3.60 Mn |
| Sep 30, 2023 | -7.12 Mn |
| Jun 30, 2023 | -4.37 Mn |
| Mar 31, 2023 | -33.50 Mn |
| Dec 31, 2022 | -54.68 Mn |
| Sep 30, 2022 | 868,000.00 |
| Jun 30, 2022 | -30.67 Mn |
| Mar 31, 2022 | 25.81 Mn |
| Dec 31, 2021 | -57.41 Mn |
| Sep 30, 2021 | -39.79 Mn |